68Ga-FF-58

N/A

Report date: 2025/03/25 14:45:50

Base Information

Drug Name68Ga-FF-58
Drug Alias Name68Ga-FF-5868Ga-FF58[68Ga]-FF58
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonistsPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsBrain NeoplasmsStomach NeoplasmsEsophageal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermanySwitzerland +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdvanced Accelerator Applications Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsBrain NeoplasmsStomach NeoplasmsEsophageal Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A